Conto economico
PRESTIGE CONSUMER HEALTHCARE INC.
PBH
Riepilogo performance
Clicca su una riga della tabella per aggiungerla al grafico
in milioni di USD
| Voce | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Mar 31, 2018 2017 FY | Mar 31, 2017 2016 FY | Mar 31, 2016 2015 FY | Mar 31, 2015 2014 FY | Mar 31, 2014 2013 FY | Mar 31, 2013 2012 FY | Mar 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ricavi
|
1,137.76 | 1,125.36 | 1,127.73 | 1,086.81 | 943.37 | 963.01 | 975.78 | 1,041.18 | 882.06 | 806.25 | 714.62 | 601.88 | 623.60 | 441.09 |
|
Costo del venduto
|
503.30 | 500.91 | 502.43 | 466.17 | 395.89 | 410.79 | 420.20 | 464.67 | - | - | - | - | - | - |
|
Utile lordo
|
634.46 | 624.45 | 625.29 | 620.65 | 547.47 | 552.22 | 555.58 | 576.51 | 500.29 | 467.21 | 406.22 | 340.05 | 347.22 | 227.38 |
|
Spese operative
|
297.69 | 282.02 | 647.71 | 290.73 | 250.07 | 261.07 | 488.07 | 360.64 | 294.67 | 206.90 | 198.66 | 151.44 | 155.33 | 124.56 |
|
Ricerca e sviluppo
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Spese commerciali, generali e amministrative
|
108.21 | 106.15 | 107.35 | 108.52 | 85.54 | 89.11 | 89.76 | 85.00 | 89.14 | 72.42 | 81.27 | 48.48 | 51.47 | 56.70 |
|
Altre spese operative
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Reddito operativo
|
336.78 | 342.43 | -22.42 | 329.92 | 297.40 | 291.16 | 67.50 | 215.87 | 205.61 | 260.32 | 207.56 | 188.62 | 191.88 | 102.82 |
|
Proventi/oneri non operativi
|
- | - | 71.50 | 67.46 | 93.29 | 100.00 | 114.78 | 108.78 | 332.29 | 438.02 | 337.66 | 314.25 | 331.45 | 41.67 |
|
Proventi da interessi
|
- | - | - | - | - | 0.34 | 0.22 | 0.39 | 85.06 | 85.88 | 73.76 | 57.45 | 57.50 | 0.02 |
|
Oneri finanziari
|
1.80 | 5.20 | 69.16 | 64.29 | 82.33 | 96.57 | 105.30 | 106.27 | 100.23 | 100.54 | 88.46 | 72.06 | 84.42 | 41.34 |
|
Altri proventi/oneri non operativi
|
-4.95 | 0.76 | -2.34 | -1.05 | 1.37 | -1.63 | 1.00 | - | - | - | - | - | - | - |
|
Risultato prima delle imposte
|
284.19 | 276.03 | -93.92 | 262.46 | 204.11 | 191.15 | -9.22 | 107.09 | 110.85 | 157.19 | 127.46 | 101.75 | 106.03 | 61.16 |
|
Imposte sul reddito
|
69.58 | 66.69 | -11.61 | 57.08 | 39.43 | 48.87 | -4.92 | -232.48 | -196.08 | -277.61 | -208.36 | -198.25 | -205.07 | 23.95 |
|
Utile di pertinenza di terzi
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Utile netto
|
214.61 | 209.34 | -82.31 | 205.38 | 164.68 | 142.28 | -42.36 | 339.57 | 69.40 | 99.91 | 78.26 | 72.62 | 65.51 | 37.21 |
Informazioni supplementari
Dati per azione, voci derivate e altre – non facenti parte del conto economico
in milioni di USD, salvo diversa indicazione
| Voce | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Mar 31, 2018 2017 FY | Mar 31, 2017 2016 FY | Mar 31, 2016 2015 FY | Mar 31, 2015 2014 FY | Mar 31, 2014 2013 FY | Mar 31, 2013 2012 FY | Mar 31, 2012 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ammortamenti e svalutazioni
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
366.95 | 373.10 | 10.21 | 362.01 | 327.57 | 320.15 | 99.28 | 249.29 | 231.41 | 283.99 | 225.30 | 202.10 | 205.12 | 113.56 |
|
Utile per azione (base)
|
4.32 | 4.21 | -1.65 | 4.09 | 3.28 | 2.81 | -0.69 | 6.40 | 1.31 | 1.89 | 1.50 | 1.41 | 1.29 | 0.74 |
|
Utile per azione diluito
|
4.29 | 4.17 | -1.65 | 4.04 | 3.25 | 2.78 | -0.69 | 6.34 | 1.30 | 1.88 | 1.49 | 1.39 | 1.27 | 0.73 |
|
Media ponderata azioni
|
49.70 | 49.76 | 49.89 | 50.26 | 50.21 | 50.72 | 52.07 | 53.10 | 52.98 | 52.75 | 52.17 | 51.64 | 50.63 | 50.27 |
|
Media ponderata diluita azioni
|
50.08 | 50.18 | 49.89 | 50.84 | 50.61 | 51.14 | 52.07 | 53.53 | 53.36 | 53.14 | 52.67 | 52.35 | 51.44 | 50.75 |
|
Conto economico complessivo
|
211.44 | 206.41 | -94.84 | 206.15 | 189.04 | 123.87 | -42.23 | 346.61 | 66.57 | 99.79 | 54.11 | 73.46 | 75.17 | 37.20 |